On the neisserial vaccine quest: Neisseria Vaccines 2007

References

• Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N. Engl. J. Med.344(18), 1378–1388 (2001).
   PubMed Web of Science ®Google Scholar
• Finne J, Bitter-Suermann D, Goridis C, Finne U. An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J. Immunol.138(12), 4402–4407 (1987).
   PubMed Web of Science ®Google Scholar
• Fredriksen JH, Rosenqvist E, Wedege E et al. Production, characterization and control of MenB-vaccine “Folkehelsa”: an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann.14(2), 67–79 (1991).
   PubMedGoogle Scholar
• Sierra GV, Campa HC, Varcacel NM et al. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann.14(2), 195–207 (1991).
   PubMedGoogle Scholar
• Boslego J, Garcia J, Cruz C et al. Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease. Vaccine13(9), 821–829 (1995).
   PubMed Web of Science ®Google Scholar
• Holst J, Feiring B, Naess LM et al. The concept of “tailor-made”, protein-based, outer membrane vesicle vaccines against meningococcal disease. Vaccine23(17–18), 2202–2205 (2005).
   PubMed Web of Science ®Google Scholar
• Rodriguez AP, Dickinson F, Baly A, Martinez R. The epidemiological impact of antimeningococcal B vaccination in Cuba. Mem. Inst. Oswaldo Cruz94(4), 433–440 (1999).
   PubMed Web of Science ®Google Scholar
• de Moraes JC, Perkins BA, Camargo MC et al. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet340(8827), 1074–1078 (1992).
   PubMed Web of Science ®Google Scholar
• Bentley SD, Vernikos GS, Snyder LA et al. Meningococcal genetic variation mechanisms viewed through comparative analysis of serogroup C strain FAM18. PLoS Genet.3(2), e23 (2007).
   PubMed Web of Science ®Google Scholar
• Tettelin H, Saunders NJ, Heidelberg J et al. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science287(5459), 1809–1815 (2000).
   PubMed Web of Science ®Google Scholar
• Tettelin H, Parkhill J. The use of genome annotation data and its impact on biological conclusions. Nat. Genet.36(10), 1028–1029 (2004).
   PubMed Web of Science ®Google Scholar
• Parkhill J, Achtman M, James KD et al. Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature404(6777), 502–506 (2000).
   PubMed Web of Science ®Google Scholar
• Uli L, Castellanos-Serra L, Betancourt L et al. Outer membrane vesicles of the VA-MENGOC-BC(R) vaccine against serogroup B of Neisseria meningitidis: analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry. Proteomics6(11), 3389–3399 (2006).
   PubMed Web of Science ®Google Scholar
• Vipond C, Suker J, Jones C et al. Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254. Proteomics6(11), 3400–3413 (2006).
   PubMed Web of Science ®Google Scholar
• Betancourt L, Gil J, Besada V et al. SCAPE: a new tool for the selective capture of peptides in protein identification. J. Proteome. Res.4(2), 491–496 (2005).
   PubMed Web of Science ®Google Scholar
• Futai M, Noumi T, Maeda M. ATP synthase (H+-ATPase): results by combined biochemical and molecular biological approaches. Annu. Rev. Biochem.58, 111–136 (1989).
   PubMed Web of Science ®Google Scholar
• Pessolani MC, Smith DR, Rivoire B et al. Purification, characterization, gene sequence, and significance of a bacterioferritin from Mycobacterium leprae. J. Exp. Med.180(1), 319–327 (1994).
   PubMed Web of Science ®Google Scholar
• Shin BK, Wang H, Yim AM et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J. Biol. Chem.278(9), 7607–7616 (2003).
   PubMed Web of Science ®Google Scholar
• Bitton RJ, Guthmann MD, Gabri MR et al. Cancer vaccines: an update with special focus on ganglioside antigens. Oncol. Rep.9(2), 267–276 (2002).
   PubMed Web of Science ®Google Scholar
• Charo J, Geluk A, Sundback M et al. The identification of a common pathogen-specific HLA class I A*0201-restricted cytotoxic T cell epitope encoded within the heat shock protein 65. Eur. J. Immunol.31(12), 3602–3611 (2001).
   PubMed Web of Science ®Google Scholar
• Dixon GL, Newton PJ, Chain BM et al. Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria. Infect. Immun.69(7), 4351–4357 (2001).
   PubMed Web of Science ®Google Scholar
• Kolb-Maurer A, Unkmeir A, Kammerer U et al. Interaction of Neisseria meningitidis with human dendritic cells. Infect. Immun.69(11), 6912–6922 (2001).
   PubMed Web of Science ®Google Scholar
• Unkmeir A, Kammerer U, Stade A et al. Lipooligosaccharide and polysaccharide capsule: virulence factors of Neisseria meningitidis that determine meningococcal interaction with human dendritic cells. Infect. Immun.70(5), 2454–2462 (2002).
   PubMed Web of Science ®Google Scholar
• Rodriguez T, Perez O, Menager N, Ugrinovic S, Bracho G, Mastroeni P. Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery. Vaccine23(10), 1312–1321 (2005).
   PubMed Web of Science ®Google Scholar
• Wetzler LM. Immunopotentiating ability of neisserial major outer membrane proteins. Use as an adjuvant for poorly immunogenic substances and potential use in vaccines. Ann. NY Acad. Sci.730, 367–370 (1994).
   PubMed Web of Science ®Google Scholar
• Perez O, Bracho G, Lastre M et al. Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern. Immunol. Cell Biol.82(6), 603–610 (2004).
   PubMed Web of Science ®Google Scholar
• Mesa C, De Leon J, Rigley K, Fernández LE. Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for Th1 induction and dendritic cell activation. Vaccine22(23–24), 3045–3052 (2004).
   PubMed Web of Science ®Google Scholar
• Al Bader T, Christodoulides M, Heckels JE, Holloway J, Semper AE, Friedmann PS. Activation of human dendritic cells is modulated by components of the outer membranes of Neisseria meningitidis. Infect. Immun.71(10), 5590–5597 (2003).
   PubMed Web of Science ®Google Scholar
• Massari P, Henneke P, Ho Y, Latz E, Golenbock DT, Wetzler LM. Cutting edge: immune stimulation by neisserial porins is Toll-like receptor 2 and MyD88 dependent. J. Immunol.168(4), 1533–1537 (2002).
   PubMed Web of Science ®Google Scholar
• Singleton TE, Massari P, Wetzler LM. Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent. J. Immunol.174(6), 3545–3550 (2005).
   PubMed Web of Science ®Google Scholar
• Al Bader T, Jolley KA, Humphries HE et al. Activation of human dendritic cells by the PorA protein of Neisseria meningitidis. Cell Microbiol.6(7), 651–662 (2004).
   PubMed Web of Science ®Google Scholar
• Trotter C, Findlow J, Balmer P et al. Seroprevalence of bactericidal and anti-outer membrane vesicle antibody to Neisseria meningitidis group B in England. Clin. Vaccine Immunol.14(7), 863–868 (2007).
   PubMedGoogle Scholar
• Ramsay ME, Andrews NJ, Trotter CL, Kaczmarski EB, Miller E. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. Br. Med. J.326(7385), 365–366 (2003).
   PubMed Web of Science ®Google Scholar
• Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet364(9431), 365–367 (2004).
   PubMed Web of Science ®Google Scholar
• Auckland C, Gray S, Borrow R et al. Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom. J. Infect. Dis.194(12), 1745–1752 (2006).
   PubMed Web of Science ®Google Scholar
• Milagres LG, Ramos SR, Sacchi CT et al. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect. Immun.62(10), 4419–4424 (1994).
   PubMed Web of Science ®Google Scholar
• Milagres LG, Gorla MC, Rebelo MC, Barroso DE. Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: effect of immunization with an outer membrane protein vaccine. FEMS Immunol. Med. Microbiol.28(4), 319–327 (2000).
   PubMedGoogle Scholar
• Tappero JW, Lagos R, Ballesteros AM et al. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA281(16), 1520–1527 (1999).
   PubMed Web of Science ®Google Scholar
• Wedege E, Hoiby EA, Rosenqvist E, Bjune G. Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial. Infect. Immun.66(7), 3223–3231 (1998).
   PubMed Web of Science ®Google Scholar
• Giuliani MM, Adu-Bobie J, Comanducci M et al. A universal vaccine for serogroup B meningococcus. Proc. Natl Acad. Sci. USA103(29), 10834–10839 (2006).
   PubMed Web of Science ®Google Scholar
• Pizza M, Scarlato V, Masignani V et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science287(5459), 1816–1820 (2000).
   PubMed Web of Science ®Google Scholar
• Yero CD, Pajon FR, Caballero ME et al. Immunization of mice with Neisseria meningitidis serogroup B genomic expression libraries elicits functional antibodies and reduces the level of bacteremia in an infant rat infection model. Vaccine23(7), 932–939 (2005).
   PubMed Web of Science ®Google Scholar
• Pon RA, Lussier M, Yang QL, Jennings HJ. N-propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis. J. Exp. Med.185(11), 1929–1938 (1997).
   PubMed Web of Science ®Google Scholar